Plain-English translation of NCT06511089 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
When you have a stroke caused by a blood clot in the brain, doctors use a procedure called endovascular thrombectomy to remove it. About 1 in 5 stroke patients also have a narrowed carotid artery (the main blood vessel in your neck). This trial is testing whether placing a stent — a small metal tube that holds the artery open — during the emergency clot removal procedure works better than treating the narrowed artery later, after you've recovered from the initial stroke.
Right now, doctors aren't sure whether it's better to fix the narrowed neck artery immediately while treating the blood clot, or to wait and do it separately later during recovery. This trial will help determine which approach gives patients the best chance of avoiding another stroke.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two groups. One group will receive a stent placed in the narrowed neck artery right away during emergency stroke treatment. The other group will receive standard care, which may include surgery or medications to treat the narrowed artery later during your recovery, depending on how severe your stroke is. All participants receive the emergency clot removal procedure; the difference is timing and approach to treating the neck artery. The trial will follow you to compare outcomes and see which approach prevents future strokes better.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
Netherlands